Cushing's syndrome: A review of diagnostic tests

Metabolism

Volumn 28, Issue 9, 1979, Pages 955-977

  Crapo, Lawrence ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE;

CORTICOTROPIN BLOOD LEVEL; CUSHING DISEASE; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSIS; ENDOCRINE SYSTEM; HYDROCORTISONE BLOOD LEVEL; METHODOLOGY; RADIOIMMUNOASSAY; REVIEW;

ADRENAL CORTEX HORMONES; CORTICOTROPIN; CUSHING SYNDROME; DEXAMETHASONE; DIAGNOSIS, DIFFERENTIAL; HUMAN; HYDROCORTISONE; INSULIN;

EID: 0018646273     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0026-0495(79)90097-0     Document Type: Review

References (222)

1. Probability theory in the diagnosis of Cushing's syndrome
2. Steroid laboratory tests in the diagnosis of Cushing's syndrome
3. The production rate of cortisol in man
4. On cortisol production rate
5. Further studies of cortisol production rate
6. Studies of hydrocortisone production as measured by isotope dilution techniques in adrenocortical diseases and in idiopathic hirsutism
7. In vivo and in vitro studies of adrenal secretions in Cushing's syndrome and primary aldosteronism
8. Appraisal of adrenocortical hyperfunction: patients with Cushing's syndrome or “non-endocrine” tumors
9. A comparison of the characteristics of increased adrenocortical function in obesity and in Cushing's syndrome
10. Clinical value of the cortisol secretion rate
11. Diagnostic value of the simultaneous determination of urinary free and conjugated cortisol in Cushing's syndrome
12. The diagnosis of hypercortisolism. Biochemical criteria differentiating patients from lean and obese normal subjects and from females on oral contraceptives
13. The diagnostic value of hypothalamic-pituitary-adrenocortical function tests in patients with Cushing's syndrome
14. A quantitative color reaction for cortisone and related 17,21-dihydroxy-20-ketosteroids
15. Chemical method for the determination of 17-hydroxycorticosteroids and 17-ketosteroids in urine following hydrolysis with β-glucuronidase
16. The determination of 17, 21-dihydroxy-20-ketosteroids in urine and plasma
17. Modification of Reddy-Jenkins-Thorn method for estimation of 17-hydroxycorticosteroids in urine
18. Assessment of adrenocortical activity by assay of 17-ketogenic steroids in urine
19. Indirect analysis of corticosteroids—the determination of 17-hydroxycorticosteroids
20. Determination of urinary 17-ketogenic steroids by means of sodium metaperiodate oxidation
21. The reliability of some adrenal function tests
22. Clinical evaluation of urinary cortisol determinations by competitive protein-binding radioassay
23. 14 in normal men
24. Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome
25. Determination of urinary unconjugated cortisol by glass fiber chromatography in the diagnosis of Cushing's syndrome
26. The ectopic ACTH syndrome
27. Steroid excretion and plasma cortisol in 41 cases of Cushing's syndrome
28. Patterns of Urinary Excretion of Steroids in Cushing's Syndrome1
29. Cushing's syndrome
30. Experience with a rapid oral metyrapone test and the plasma ACTH content in determining the cause of Cushing's syndrome
31. Cushing's syndrome: a prospective study of diagnostic methods
32. Adrenocortical function in obesity and Cushing's syndrome
33. An evaluation of laboratory tests for the detection and differential diagnosis of Cushing's syndrome
34. Surgical experience with Cushing's disease
35. Cushing's disease—selective trans-sphenoidal resection of pituitary microadenomas
36. Urinary cortisol excretion as a test of adrenal cortical function
37. Cushing's syndrome: diagnostic criteria
38. Cushing's syndrome: adrenocortical hyperactivity secondary to neoplasma arising outside the pituitary-adrenal system
39. Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis
40. Urinary excretion of cortisol in Cushing's syndrome: effect of corticotropin
41. Urinary cortisol excretion in stress situations and in patients with Cushing's syndrome
42. A method for the determination of 17-hydroxycorticosteroids in blood: 17-hydroxycorticosterone in the peripheral circulation
43. Determination of 17, 21-dihydroxy-20-ketosteroids in blood plasma
44. Evaluation of Silber-Porter procedure for determination of plasma hydrocortisone
45. Fluorimetric determination of free plasma 11-hydroxycorticosteroids in man
46. A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma
47. The determination of adrenocortical steroids in blood: observations on the reliability of a simple fluorimetric method for cortisol
48. Simple method for the determination of plasma corticoids
49. Double isotope derivative assay of aldosterone in biological extracts
50. Cortisol is secreted episodically by normal man
51. ACTH and cortisol secretory patterns in man
52. Characterization of the normal temporal pattern of plasma corticosteroid levels
53. Episodic variation in plasma corticosteroids in subjects with Cushing's syndrome of differing etiology
54. Simultaneous measurement of multiple plasma steroids by radioimmunoassay demonstrating episodic secretion
55. Simultaneous study of cortisol and TSH daily variations in normal subjects and patients with hyperadrenalcorticism
56. Cortisol is secreted episodically in Cushing's syndrome
57. Repeated plasma cortisol determinations in Cushing's syndrome due to adrenocortical adenoma
58. Short-term fluctuations in plasma cortisol in Cushing's syndrome
59. The diurnal variation of plasma levels and urinary excretion of 17-hydroxycorticosteroids in normal subjects, night workers, and blind subjects
60. Studies of the diurnal variation of plasma 17-hydroxycorticosteroids in man
61. Plasma 17-hydroxycorticosteroids in Cushing's syndrome
62. Disorders of the adrenal cortex and pituitary gland
63. Circadian rhythm of plasma 11-hydroxycorticosteroids in depressive illness, congestive heart failure, and Cushing's syndrome
64. Concentration of corticosterone and cortisol in peripheral plasma of patients with adrenocortical hyperplasia and normal subjects
65. Cushing's syndrome—a review of 50 patients in 15 years
66. Normal and abnormal regulation of corticotropin secretion in man
67. Alcohol-induced Cushingoid syndrome.
68. Alcohol-induced pseudo-Cushing's syndrome
69. Plasma cortisol response to lysine-vasopressin: comparison with other tests of human pituitary-adrenocortical function
70. The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects
71. The insulin tolerance test in assessment of the hypothalamic-pituitary-adrenal axis. I. Normal persons
72. Tests of hypothalamic-pituitary-adrenal function of man
73. Evaluation of three tests of hypothalamic-pituitary-adrenal function
74. The insulin tolerance test in assessment of the hypothalamic-pituitary-adrenal axis. II. Patients with hypothalamic and pituitary disorders and patients with anorexia nervosa
75. A fundamental defect of adrenocortical control in Cushing's disease
76. Pituitary response to stress in Cushing's disease
77. Cushing's syndrome
78. Responses of plasma ACTH, GH, LH, and 11-hydroxycorticosteroids to various stimuli in patients with Cushing's syndrome
79. Radioimmunoassay of plasma adrenocorticotropin in Cushing's syndrome
80. Plasma ACTH and cortisol responses to TRF, vasopressin, or hypoglycemia in Cushing's disease and Nelson's syndrome
81. Pituitary-adrenal function in severe depressive illness
82. Diagnosis of Cushing's syndrome—single dose dexamethasone suppression test
83. A rapid screening test for Cushing's syndrome
84. Rapid dexamethasone suppression test for Cushing's syndrome
85. Screening test for Cushing's syndrome with plasma 11-hydroxycorticosteroids
86. Single-dose dexamethasone suppression test for Cushing's syndrome
87. Single-dose dexamethasone suppression in normal subjects and hospital patients
88. Simplified dexamethasone suppression test
89. Experience with a short test of pituitary-adrenal function
90. A rapid screening test for Cushing's syndrome
91. Conjugated estrogens and the overnight dexamethasone suppression test
92. Suppression of activity of the adrenal cortex by dexamethasone in Cushing's syndrome
93. Cushing's syndrome in childhood: report of two cases with bilateral adrenocortical hyperplasia, showing distinctive clinical features
94. Apparently normal pituitary-adrenal suppressibility in Cushing's syndrome: dexamethasone metabolism and plasma levels
95. Cure of Cushing's disease by transsphenoidal removal of a microadenoma from a pituitary gland despite a radiographically normal sella turcica
96. Normal suppression to dexamethasone in Cushing's disease: an expression of decreased metabolic clearance for dexamethasone
97. An unusual case of Cushing's syndrome
98. Adrenal function and the complications of diabetes mellitus
99. Measurement of plasma cortisol in the diagnosis of Cushing's syndrome
100. Effect of diphenylhydantoin on the metabolism of dexamethasone
101. Evaluation of stimulation and suppression tests on the etiological diagnosis of Cushing's syndrome
102. The adrenal cortex
103. Clinical and laboratory studies of ectopic humoral syndrome
104. Results of treatment in 108 patients with Cushing's syndrome
105. Primary Adrenocortical Nodular Dysplasia: A Rare Cause of Cushing's Syndrome1
106. Severe osteopenia in young adults associated with Cushing's syndrome due to micronodular adrenal disease
107. Dexamethasone-suppressible adrenocortical tumor
108. ACTH-responsive, dexamethasone-suppressible adrenocortical carcinoma
109. Diagnosis and Treatment of Cushingʼs Syndrome
110. Cushing's syndrome with atypical biochemical results
111. Observations and comments on failure of dexamethasone suppression
112. Reliability and significance of the dexamethasone suppression test in Cushing's disease
113. Radioimmunoassayable ACTH in dexamethasone nonsuppressible Cushing's syndrome
114. Periodic hormonogenesis—a new phenomenon. Periodicity in function of a hormone-producing tumor in man
115. Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone
116. Periodic remission in Cushing's disease with paradoxical dexamethasone response: an expression of periodic hormonogenesis
117. Cushing syndrome with cyclical edema and periodic secretion of corticosteroids
118. The assay of ACTH in plasma
119. ACTH and MSH assays and their clinical application
120. The impact of radioimmunoassay on our understanding of human adrenal physiology
121. ACTH, lipotrophin and MSH in health and disease
122. β-endorphin and ACTH are secreted concomitantly by the pituitary gland
123. Immunoreactive endorphins, lipotropins and corticotropins in a human nonpituitary tumor: evidence for a common precursor
124. High molecular weight forms of ACTH are glycoproteins
125. Common precursor to corticotropins and endorphins
126. High molecular weight forms of human ACTH are glycoproteins
127. Radioimmunoassay of β-MSH in human plasma and tissues
128. Normal and abnormal regulation of β-MSH in man
129. Plasma immunoreactive corticotrophin and lipotrophin in Cushing's syndrome and Addison's disease
130. Human plasma immunoreactive β-lipotropin: correlation with basal and stimulated plasma ACTH concentrations
131. Diurnal rhythm and disappearance half-time of endogenous plasma immunoreactive β-MSH (LPH) and ACTH in man
132. A specific radioimmunoassay for human β-lipotropin
133. Dissociation of the disappearance of bioactive and radioimmunoreactive ACTH from plasma in man
134. A comparison of bioassay and radioimmunoassay for plasma ACTH in man
135. Relationship of bioassayable and immunoassayable plasma ACTH and cortisol concentrations in normal subjects and in patients with Cushing's disease
136. Measurement of corticosterone in rat adrenal venous plasma as a bioassay for ACTH
137. A sensitive biologic assay for ACTH
138. Blood ACTH levels in Cushing's disease
139. Cause of Cushing's syndrome in patients with tumors arising from nonendocrine tissue
140. ACTH in human plasma
141. Correlation of plasma ACTH concentrations with adrenocortical response in normal human subjects, surgical patients, and patients with Cushing's disease
142. Nonpituitary neoplasms and Cushing's syndrome
143. Plasma ACTH determinations in 58 patients before or after adrenalectomy for Cushing's syndrome
144. Studies of ACTH secretion control in 116 cases of Cushing's syndrome
145. Radioreceptor assay of adrenocorticotropic hormone: new approach to assay of polypeptide hormones in plasma
146. Adrenocorticotropin measurement by competitive binding receptor assay
147. Isolated adrenal cortex cells: hypersensitivity to ACTH after hypophysectomy
148. A sensitive bioassay for the determination of human plasma ACTH levels
149. A sensitive bioassay for ACTH in human plasma
150. Comparison of the Redox Assay for ACTH with Previous Assays
151. Circulating ACTH levels in severe hypopituitarism and in the neonate
152. General introduction to cytochemical hormone bioassay
153. The cytochemical bioassay of ACTH
154. THE CYTOCHEMICASL SECTION ASSAY FOR CORTICOTROPHIN
155. Validation of the redox cytochemical assay for ACTH
156. Application of the cytochemical bioassay for ACTH to clinical and physiological studies in man
157. Studies on the mechanism of cytochemical bioassays
158. Radioimmunoassay of ACTH in plasma
159. ACTH radioimmunoassay: interpretation, comparison with bioassay, and clinical application
160. HOMOLOGOUS RADIOIMMUNOASSAY FOR PLASMA-LEVELS OF CORTICOTROPHIN IN MAN
161. Spontaneous and stimulated secretion of QUSO-extractable immunoassayable ACTH in man
162. Factors influencing the circadian periodicity of adrenal steroid levels
163. Nyctohemeral variation and suppressibility of plasma ACTH in various stages of Cushing's disease
164. A sensitive radioimmunoassay for plasma ACTH levels
165. Plasma levels of immunoreactive corticotrophin in patients with Cushing's syndrome
166. Tumour and plasma ACTH concentrations in patients with and without the ectopic ACTH syndrome
167. Biologic and Immunologic Characterization and Physical Separation of ACTH and ACTH Fragments in the Ectopic ACTH Syndrome
168. Tests in Cushing's syndrome
169. A new phenomenon of usefulness in the radioimmunoassay of plasma adrenocorticotropic hormone
170. Measurement of pituitary hormones: clinical applications. 2. ACTH
171. Preparation and evaluation of ACTH antibodies
172. Application of ACTH assays in a routine clinical laboratory
173. Paradoxical ACTH response to glucocorticoids in Cushing's disease
174. Treatment of Cushing's syndrome with trilostane (WIN 24, 549), an inhibitor of adrenal steroid biosynthesis
175. Selective venous sampling to differentiate ectopic ACTH secretion from pituitary Cushing's syndrome
176. Secretion of ACTH and β-MSH by an adrenal medullary paraganglioma
177. Cushing's syndrome with dual pituitary-adrenal control
178. Dual sites of inhibition by metyrapone of human adrenal steroidogenesis: correlation of in vivo and in vitro studies
179. ALTERATIONS OF ADRENAL STEROID PATTERNS IN MAN RESULTING FROM TREATMENT WITH A CHEMICAL INHIBITOR OF 11 βHYDROXYLATION
180. Plasma metyrapone, ACTH, cortisol, and deoxycortisol levels
181. Clinical application of a new test of pituitary reserve
182. QUANTITATION OF THE ACCELERATING EFFECT OF METYRAPONE ON CORTISOL METABOLISM
183. Extraadrenal effects of metyrapone in man
184. Some factors determining the adrenal response to metyrapone
185. An assessment of the metyrapone test
186. Direct and indirect estimation of pituitary ACTH reserves in man following adrenal steroid therapy
187. Indirect Estimation of Pituitary Corticotropin Reserve in Man by Use of an Adrenocortical 11 β-hydroxylase Inhibitor (SU-4885 Ciba)
188. 17-hydroxycorticosteroids and 17-ketogenic steroids in the assessment of pituitary reserve by metopirone
189. Assessment of pituitary ACTH secretory capacity with metapirone: 1. Interpretation
190. Falsely abnormal responses of normal subjects to the metapirone test for pituitary reserve
191. Cushing's syndrome. V. Chemical inhibition of 11 β-hydroxylating enzyme systems in hyperplastic and neoplastic adrenal glands
192. Partial pituitary ablation with implants of gold-198 and yttrium-90 for Cushing's syndrome with associated adrenal hyperplasia
193. Cushing's syndrome caused by a metyrapone responsive adrenocortical adenoma
194. Quantitation of pituitary ACTH reserve in man by use of adrenocortical 11-beta hydroxylase inhibitor (SU-4885)
195. Clinical use of a new diagnostic agent, methopyrapone (SU-4885), in pituitary and adrenocortical disorders
196. A test of pituitary reserve utilizing intravenous SU-4885 with a new method for extraction of 11-desoxycorticosteroids
197. Plasma and Urinary 11-Desoxycorticosteroid (11-DOCS) Response to Metyrapone in Pituitary, Renal and Hepatic Disease
198. The metyrapone test of pituitary function
199. Plasma 11-deoxycorticosteroid and ACTH response to metyrapone (plasma metyrapone test)
200. Simplified metyrapone test with determination of plasma 11-deoxycortisol (metyrapone test with plasma S)
201. Effect of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man
202. Effect of estrogen on the metabolism of metyrapone and release of ACTH
203. Single-dose metyrapone test
204. Evaluation of single oral dose metyrapone tests in children with hypopituitarism
205. Assessment of the pituitary adrenal cortex axis in children by a single dose metyrapone test
206. A comparison of the adrenal responses to hypoglycemia, metyrapone and ACTH
207. Single-dose metyrapone test
208. Plasma 11-deoxycortisol radioimmunoassay for metyrapone tests
209. Short time kinetics of deoxycorticosterone, deoxycortisol, corticosterone and cortisol during single dose metyrapone test.
210. Single dose metyrapone test: 11 β-hydroxylase inhibition by metyrapone and reduced metyrapone assayed by radioimmunoassay
211. Nonchromatographic radioimmunoassay of plasma 11-deoxycortisol, for use in the metyrapone test, with polyethylene glycol as the precipitant
212. Simplified assessment of pituitary-adrenal reserve. Measurement of serum 11-deoxycortisol and cortisol after metyrapone
213. Evaluation of 3 hour metyrapone test in children and adolescents
214. Advances in the diagnosis of altered states of adrenocortical function
215. Acute unilateral adrenal hemorrhage following ACTH administration in a patient with Cushing's syndrome
216. Adrenal venography
217. Adrenal venography: clinical roentgenographic correlation in 80 patients
218. 131I-19-iodocholesterol
219. Efficacy of radiocholesterol imaging of the adrenal glands in Cushing's syndrome
220. 131I-6β-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans
221. The pituitary fossa in Cushing's syndrome. A retrospective analysis of 93 patients
222. Transsphenoidal removal of pituitary microadenoma in Cushing's disease